ES478718A1 - Procedimiento para la obtencion de lipopeptidos. - Google Patents

Procedimiento para la obtencion de lipopeptidos.

Info

Publication number
ES478718A1
ES478718A1 ES478718A ES478718A ES478718A1 ES 478718 A1 ES478718 A1 ES 478718A1 ES 478718 A ES478718 A ES 478718A ES 478718 A ES478718 A ES 478718A ES 478718 A1 ES478718 A1 ES 478718A1
Authority
ES
Spain
Prior art keywords
formula
group
compounds
carboxyl
free
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES478718A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES478718A1 publication Critical patent/ES478718A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C07K5/06069Ser-amino acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Procedimiento para la obtención de lipopéptidos de fórmula **fórmula** donde R1 y R2, en cada caso significan un resto hidrocarburo, saturado o insaturado, alifático, o mixto alifático-cicloalifático, en caso dado sustituido por funciones de oxígeno, con 11- 21 átomos de carbono, R3 significa hidrógeno o el resto R1-CO-O-H2- donde R1 tiene el mismo significado y X es un aminoácido alifático natural, peptídicamente enlazado, con carboxilo libre, esterificado o amidado, o una secuencia de aminoácidos de 2-10 aminoácidos alifáticos naturales, cuyo grupo carboxilo terminal se presenta en forma libre, esterificada o amidada o X=OH donde los centros de asimetría designados con * o bién ** tienen la configuración S absoluta o bien la configuración S o R, y en caso dado, las mezclas de los compuestos R y S epímeros en los átomos C** y en caso dado las sales y los complejos, caracterizado porque un compuesto de fórmula **fórmula** donde R2 tiene el significado indicado para la fórmula (I) y R3 significa hidrógeno o el grupo HO-CH2, y Z2 es OH o representa un grupo correspondiente a X en la fórmula (I) donde sin embargo en una secuencia de péptido o en un solo péptido donde sin embargo no estén presentes grupos hidroxi libres, o un derivado de un compuesto de estos, donde Z2 es Oh, pero con grupo protector carboxilo activado, o una sal de uno de estos compuestos, se acila en forma en si conocida, y si se desea, en los compuestos obtenidos con grupo carboxilo terminar éste se transforma en un grupo amida o grupo éster, y/o un grupo protector carboxilo se libera y/o los compuestos se transforman en sus sales o complejos.
ES478718A 1977-06-20 1979-03-16 Procedimiento para la obtencion de lipopeptidos. Expired ES478718A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU77584 1977-06-20

Publications (1)

Publication Number Publication Date
ES478718A1 true ES478718A1 (es) 1979-12-16

Family

ID=19728618

Family Applications (3)

Application Number Title Priority Date Filing Date
ES470961A Expired ES470961A1 (es) 1977-06-20 1978-06-20 Procedimiento para la obtencion de lipopeptidos
ES478718A Expired ES478718A1 (es) 1977-06-20 1979-03-16 Procedimiento para la obtencion de lipopeptidos.
ES478717A Expired ES478717A1 (es) 1977-06-20 1979-03-16 Procedimiento para la obtencion de lipopetidos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES470961A Expired ES470961A1 (es) 1977-06-20 1978-06-20 Procedimiento para la obtencion de lipopeptidos

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES478717A Expired ES478717A1 (es) 1977-06-20 1979-03-16 Procedimiento para la obtencion de lipopetidos.

Country Status (18)

Country Link
EP (1) EP0000330B1 (es)
JP (2) JPS549224A (es)
AT (1) AT364095B (es)
AU (1) AU525005B2 (es)
CA (1) CA1139305A (es)
DD (1) DD139257A5 (es)
DE (1) DE2860893D1 (es)
DK (1) DK275178A (es)
ES (3) ES470961A1 (es)
FI (1) FI781933A7 (es)
GR (1) GR71681B (es)
IE (1) IE46957B1 (es)
IL (1) IL54950A (es)
NO (1) NO148921C (es)
NZ (1) NZ187611A (es)
PL (3) PL207766A1 (es)
PT (1) PT68188A (es)
ZA (1) ZA783504B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014815A3 (de) * 1978-12-20 1980-10-29 Ciba-Geigy Ag Peptidderivate, Verfahren zu deren Herstellung und Zwischenprodukte sowie pharmazeutische Präparate mit einer dieser Verbindungen
DE3485094D1 (de) * 1983-01-25 1991-10-31 Ciba Geigy Ag Neue peptidderivate.
FR2546164B1 (fr) * 1983-05-16 1987-07-17 Centre Nat Rech Scient Nouveaux derives de peptides, leur preparation et leur application comme inhibiteurs de l'elastase
US6024964A (en) * 1985-06-24 2000-02-15 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
DE3546150A1 (de) * 1985-06-24 1987-01-22 Hoechst Ag Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung
US6074650A (en) * 1985-06-24 2000-06-13 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
DE3522638A1 (de) * 1985-06-25 1987-01-08 Diamalt Ag Neue somatostatin-derivate
FR2611205B1 (fr) * 1987-02-20 1990-03-02 Serbio Dipeptides, procede de preparation et utilisation dans le dosage de proteases
EP0306912A3 (en) * 1987-09-08 1989-07-05 Albany Medical College Immunogenic composites capable of selectively inducing antibody production and pharmaceutical compositions employing the same.
DE4119856A1 (de) * 1991-06-17 1992-12-24 Hoechst Ag N-acyl-s-(2-hydroxyalkyl)-cysteine, deren herstellung sowie deren verwendung als zwischenprodukte zur herstellung von synthetischen immunadjuvantien und synthetischen impfstoffen
DE59207848D1 (de) * 1991-12-19 1997-02-20 Ciba Geigy Ag Aminosulfonsäurederivate und Verfahren zu ihrer Herstellung
AU666789B2 (en) * 1992-12-28 1996-02-22 Takeda Chemical Industries Ltd. 2-amino-6,7-dihydroxy-4-thiaheptanoic acid derivatives, production and use thereof
EP0604945A1 (en) 1992-12-28 1994-07-06 Takeda Chemical Industries, Ltd. TAN-1511, its derivatives, production and use thereof
EP0641776A3 (en) * 1993-09-08 1997-05-02 Takeda Chemical Industries Ltd Thioglycerol derivatives.
GB9930591D0 (en) * 1999-12-23 2000-02-16 Univ London Component for vaccine
DE10048840A1 (de) * 2000-10-02 2002-04-11 Biotechnolog Forschung Gmbh Verwendung von Lipopeptiden oder Lipoproteinen zur Behandlung von Lungeninfektionen und -tumoren
FR2816060A1 (fr) * 2000-10-27 2002-05-03 Pf Medicament Procede d'identification de nouvelles molecules se liant au recepteur lox et utilisation de ces molecules
NZ565063A (en) 2005-06-13 2011-04-29 Cleveland Biolabs Inc Methods of protecting against apoptosis using lipopeptides
WO2007014193A2 (en) * 2005-07-25 2007-02-01 Therimunex, Llc Peptidyl diacylglycerides
DE102016005550B4 (de) 2016-05-09 2024-09-26 Hans-Georg Rammensee Adjuvans zur lnduzierung einer zellulären lmmunantwort
MX2020004742A (es) * 2017-11-06 2020-08-13 Crown Equip Corp Sistema de colocacion lateral de vehiculo industrial.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE785933A (fr) * 1971-07-07 1973-01-08 Ciba Geigy Procede de preparation de peptides contenant de la cystine
ZA735680B (en) * 1972-09-21 1974-07-31 Hoffmann La Roche Polypeptides
DE2706490A1 (de) 1976-02-20 1977-08-25 Ciba Geigy Ag Neue carbonsaeureester

Also Published As

Publication number Publication date
ES478717A1 (es) 1979-12-16
PT68188A (de) 1978-07-01
NZ187611A (en) 1981-07-13
ES470961A1 (es) 1980-03-01
ZA783504B (en) 1979-06-27
IE46957B1 (en) 1983-11-16
GR71681B (es) 1983-06-21
IE781227L (en) 1978-12-20
DK275178A (da) 1978-12-21
NO148921C (no) 1984-01-11
NO782138L (no) 1978-12-21
DD139257A5 (de) 1979-12-19
ATA445178A (de) 1981-02-15
JPS641466B2 (es) 1989-01-11
AU3723078A (en) 1980-01-03
JPS6360760B2 (es) 1988-11-25
IL54950A (en) 1983-10-31
DE2860893D1 (en) 1981-11-05
AT364095B (de) 1981-09-25
PL207766A1 (pl) 1979-11-19
FI781933A7 (fi) 1978-12-21
EP0000330A1 (de) 1979-01-24
IL54950A0 (en) 1978-08-31
CA1139305A (en) 1983-01-11
PL216739A1 (es) 1980-05-19
JPS549224A (en) 1979-01-24
JPS6372671A (ja) 1988-04-02
AU525005B2 (en) 1982-10-14
PL216740A1 (es) 1980-05-19
NO148921B (no) 1983-10-03
EP0000330B1 (de) 1981-08-05

Similar Documents

Publication Publication Date Title
ES478718A1 (es) Procedimiento para la obtencion de lipopeptidos.
ES2057746T3 (es) Monoamidas de dtpa, agentes farmaceuticos que contienen estos compuestos, su utilizacion y procedimientos para su preparacion.
ES8601994A1 (es) Un procedimiento para la preparacion de pirazolo-y piridazo-pirazolinas,-piridazinas y-diazepinas.
MX172089B (es) Composicion mejorada de concentrado de aditivo
ES2094309T3 (es) Esteres de acidos grasos de acido isetionico alcoxilado y composiciones detergentes que comprenden los mismos.
ES2128307T3 (es) Derivados de 1,4,7,10-tetraaza-ciclododecano monosustituidos en n, procedimiento para su preparacion y agentes farmaceuticos que los contienen.
ES8405364A1 (es) Metodo de preparar amidoaminoacidos n-substituidos.
ES8703842A1 (es) Procedimiento para preparar derivados de menalonolactona.
ES8603501A1 (es) Un procedimiento para preparar un derivado de 1,8-naftiridina
DE69212925D1 (de) Polymerisationsinhibitoren für Acrylsäure und Ester
GB1494603A (en) N-(perfluoroalkanoyl)-n-phosphonomethyl glycine compounds
AR011957A1 (es) Derivados de dolastatina 15 con funcionalidades carbonilo y heterociclicas en el c-terminal
ES8401026A1 (es) Procedimiento para la obtencion de acidos 1-carboxi-(azaalcanoil o azaaralcanoil)-indolin-2-carboxilicos.
ATE19251T1 (de) Hemmer der kollagenase der saeugetiere.
ES2095942T3 (es) Derivados de bencenoacetamida inhibidores del vih.
ATE11920T1 (de) 4-pregnen-derivate, verfahren zu ihrer herstellung und zusammensetzungen zur behandlung von entzuendungen.
SE8107634L (sv) Nya tri-, tetra- och pentapeptider, forfaranden for framstellning av desamma och lekemedel innehallande desamma
ATE37360T1 (de) Ester von imidazolaethanol.
ES8706622A1 (es) Procedimiento para preparar alfa-aminoacidos sustituidos
ES2188743T3 (es) Compuestos de acido pirrolidinilhidroxamico y procedimiento de produccion de los mismos.
DK528086D0 (da) N-substituerede 3-piperidincarboxylsyrer eller n-substituerede 3-pyridincarboxylsyrer og derivater deraf
ES460618A1 (es) Procedimiento para la preparacion de derivados de peptido
GB1199508A (en) Emollients comprising Novel Diester derived from Sterically Hindered Carboxylic Acids, and their preparation
MX3330E (es) Procedimiento para la preparacion de 9-alcohilamino-eritromicinas y sus sales
ES2046189T3 (es) Derivados de dihidropiridina y composiciones de los mismos.